A practitioner may conduct certain schedule I research under an alternative process
What the document says“``(1) In general.--Notwithstanding subsection (g), a practitioner may conduct research described in paragraph (2) of this subsection with 1 or more schedule I substances in accordance with subparagraph (A) or (B) of paragraph (3) of this subsection.”
The opening of a new subsection (n) added to section 303 of the Controlled Substances Act (21 U.S.C. 823). A practitioner may conduct the research described in paragraph (2) with one or more schedule I substances by following either of the two routes in paragraph (3), rather than the route in subsection (g) of that section. What subsection (g) provides is in the amended statute, which is not indexed here.
What the document actually says“``(1) In general.--Notwithstanding subsection (g), a practitioner may conduct research described in paragraph (2) of this subsection with 1 or more schedule I substances in accordance with subparagraph (A) or (B) of paragraph (3) of this subsection.”
A researcher can do some work with the strictest drugs. They must follow one of two routes set out below. Those routes come in place of the older one.
Schedule I is the strictest list in drug law. Work with those drugs needs the say-so of the government. This adds a faster way to get it.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.